Fidelis Capital Partners’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$293K Sell
4,582
-1,092
-19% -$71.8K 0.02% 438
2026
Q1
$404K Sell
5,674
-4,644
-45% -$366K 0.03% 352
2025
Q4
$846K Buy
10,318
+1,042
+11% +$81.2K 0.06% 230
2025
Q3
$697K Buy
+9,276
New +$692K 0.05% 249
2025
Q1
– Sell
-2,679
Closed -$234K – 444
2024
Q4
$234K Buy
+2,679
New +$228K 0.02% 385

Other funds holding GEHC

Fidelis Capital Partners's GEHC Position: Q2 2026 in Review

Fidelis Capital Partners reduced its GE HealthCare (GEHC) stake by 19% in Q2 2026, selling an estimated $71.8K and leaving 4,582 shares worth $293K. The position accounts for 0.02% of the portfolio, ranked #438.

Fidelis Capital Partners first reported a position in GEHC in Q4 2024 and has held it in 5 quarters since. The position peaked at $846K in Q4 2025. 1,233 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Fidelis Capital Partners held 4,582 shares of GE HealthCare worth $293K as of Q2 2026.
  • Fidelis Capital Partners sold 1,092 GE HealthCare shares in Q2 2026, an estimated $71.8K.
  • GE HealthCare made up 0.02% of Fidelis Capital Partners's portfolio in Q2 2026, its #438 holding.
  • Fidelis Capital Partners first reported a position in GE HealthCare in Q4 2024 and has held it in 5 quarters since.
  • Fidelis Capital Partners's GE HealthCare position peaked at $846K in Q4 2025.
  • 1,233 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Fidelis Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.